07/17/2024
3:19 PM | Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:22 PM | Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:53 PM | Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:20 PM | Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:23 PM | Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
8:03 AM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
4:26 PM | Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
06/04/2024
4:28 PM | Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
8:15 AM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
4:17 PM | Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:33 PM | Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
3:16 PM | Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
3:18 PM | Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:20 PM | Ocular Therapeutix (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
3:22 PM | Ocular Therapeutix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/29/2024
3:19 PM | Ocular Therapeutix (Filer)
| Form ARS | |
03/29/2024
4:11 PM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
3:23 PM | Ocular Therapeutix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
3:43 PM | Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
7:02 PM | Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/26/2024
7:04 PM | Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/26/2024
7:06 PM | Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
7:07 PM | Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:00 AM | Ocular Therapeutix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
6:34 AM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:48 PM | Ocular Therapeutix (Subject)
Opaleye Management Inc. (Filed by)
| Form SC 13G/A | |
02/06/2024
5:35 PM | Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
5:38 PM | Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
5:26 PM | Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
5:29 PM | Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
5:32 PM | Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:41 PM | Ocular Therapeutix (Subject)
White Christopher G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
3:33 PM | Notman Donald (Reporting)
Ocular Therapeutix (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
3:36 PM | Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
3:39 PM | Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
6:00 PM | Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:01 PM | Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:01 PM | Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:02 PM | Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:03 PM | Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:34 PM | Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Nvidia’s Quiet $1 Trillion Pivot (Ad) Nvidia recently added $277 billion in market cap …
IN ONE DAY. Find out details on these three critical Nvidia partners immediately. |
01/31/2024
4:36 PM | Ocular Therapeutix (Subject)
White Christopher G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
4:39 PM | Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
4:41 PM | Notman Donald (Reporting)
Ocular Therapeutix (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
4:31 PM | Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
Ocular Therapeutix (Subject)
| Form SC 13G/A | |
01/25/2024
7:04 AM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:17 PM | Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
12/22/2023
3:04 PM | Deep Track Capital, LP (Filed by)
Ocular Therapeutix (Subject)
| Form SC 13G | |
12/18/2023
3:52 PM | Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:52 PM | Ocular Therapeutix (Subject)
SUMMER ROAD LLC (Filed by)
| Form SC 13D/A | |
12/14/2023
3:09 PM | Ocular Therapeutix (Filer)
| Form 424B5 | |
12/14/2023
7:46 AM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
11:15 PM | Ocular Therapeutix (Filer)
| Form EFFECT | |
11/07/2023
4:06 PM | Ocular Therapeutix (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/04/2023
8:02 AM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
6:07 AM | Ocular Therapeutix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
7:27 AM | Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
7:45 PM | Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
